Who is sponsoring NCT03994445?

NCT03994445 is sponsored by Ibtihal Altalhi.

What drugs are being tested in NCT03994445?

Interventions in NCT03994445: Mobile Phone-Based Intervention.

What condition does NCT03994445 study?

NCT03994445 studies Smoking Cessation.

Is NCT03994445 still recruiting?

NCT03994445 is currently status unknown. Last updated 21 June 2019.

Last reviewed 2019-06-21 · How we verify

NCT03994445

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Mobile Phone-Based Intervention to Prevent Smoking Relapse Among Recent Smoking Quitters

Status unknown NA Last updated 21 June 2019

What this trial tests

NA trial testing Mobile Phone-Based Intervention in Smoking Cessation in 476 participants. Status unknown.

Timeline

1 July 2019

Primary endpoint
31 March 2020

30 April 2020

Quick facts

Lead sponsor	Ibtihal Altalhi
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	476
Start date	1 July 2019
Primary completion	31 March 2020
Estimated completion	30 April 2020
Sites	1 location across Saudi Arabia

Drugs / interventions tested

Mobile Phone-Based Intervention

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →

Sponsor

Ibtihal Altalhi

Who can join

Adults 18 to 65, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Main Objective The main objective of the study is to investigate the effectiveness of a mobile phone-based intervention in reducing relapse ate among recent quitters who are attending the smoking cessation program in Jazan. Besides this, the study will achieve the following objective: To identify the timing and different factors associated with relapse process among recent quitters during first 6 months of quitting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03994445 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ibtihal Altalhi
Last refreshed: 21 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03994445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing